Last reviewed · How we verify

NCT03290924

Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach

Completed NA Last updated 25 September 2017
What this trial tests

NA trial testing Low dose high frequency health worker training approach in Stillbirth in 40 participants. Completed in 28 February 2017.

Timeline
1 September 2014
Primary endpoint
28 February 2017
28 February 2017

Quick facts

Lead sponsorJhpiego
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment40
Start date1 September 2014
Primary completion28 February 2017
Estimated completion28 February 2017

Drugs / interventions tested

Conditions studied

Sponsor

Jhpiego — full company profile →

Who can join

Eligibility, any sex, with Stillbirth or Neonatal Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assesses the effect of a low-dose, high-frequency training approach on long-term evidence-based skill retention among skilled birth attendants and impact on adverse birth outcomes at hospitals in Ghana.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Accelerating newborn survival in Ghana through a low-dose, high-frequency health worker training approach: a cluster randomized trial.
    Gomez PP, Nelson AR, Asiedu A, Addo E, et al · · 2018 · cited 53× · PMID 29566659 · DOI 10.1186/s12884-018-1705-5
  2. <i>"It builds your confidence… you've done well"</i>: Healthcare workers' experiences of participating in a low-dose, high-frequency training to improve newborn survival on the day of birth in Ghana.
    Asiedu A, Nelson AR, Gomez PP, Tappis H, et al · · 2019 · cited 10× · PMID 31410394 · DOI 10.12688/gatesopenres.12936.1

Verify or expand the search:

Other recruiting trials for Stillbirth

Currently open trials in the same condition.

Other Jhpiego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03290924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing